Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $9.55 and last traded at $9.43, with a volume of 19301 shares changing hands. The stock had previously closed at $9.35.
Fresenius SE & Co. KGaA Trading Up 0.5 %
The firm has a 50-day moving average of $8.64 and a 200 day moving average of $7.81.
Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report) last posted its earnings results on Wednesday, July 31st. The company reported $0.22 earnings per share (EPS) for the quarter. The company had revenue of $5.83 billion for the quarter. As a group, research analysts predict that Fresenius SE & Co. KGaA will post 0.82 EPS for the current fiscal year.
Fresenius SE & Co. KGaA Company Profile
Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
Read More
- Five stocks we like better than Fresenius SE & Co. KGaA
- Top Stocks Investing in 5G Technology
- Matador Resources Insiders Keep Buying Its Stock, Should You?
- NYSE Stocks Give Investors a Variety of Quality OptionsÂ
- Oracle Can Turn the Magnificent 7 Into 8: Here’s Why
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Palantir Stock Is Up 14% on S&P 500 News: Is It Time to Buy?
Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
